InSphero
Provides 3D microtissues used for more PREdictive drug screening
InSphero has raised €21M across 3 funding rounds from 1 investor, most recently a Series C round in Jul 2015. Based in Schlieren, Switzerland; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€21M
€20,794,219
Funding rounds
3
Investors
1
distinct backers
Active since
2010-08
latest 2015-07
Funding by year
EUR raised per yearInSphero — funding by year — interactive chart.
Data table
| InSphero — funding by year | |
|---|---|
| 2010 | €1.3M |
| 2013 | €1.6M |
| 2015 | €18M |
Signals
Medium confidenceRaise-next likelihood11
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood7
base rate 11% (2+ rounds)
- ▼ Old (17y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-07-01 | Series C | €18M | — | View deal → |
| 2013-06-01 | Series B | €1.6M | — | View deal → |
| 2010-08-01 | Series A | €1.3M | Redalpine | View deal → |
Investors
1Acquisitions
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData